Search results
Results from the WOW.Com Content Network
Charcot–Marie–Tooth disease type 1D CMT1E Charcot–Marie–Tooth disease type 1E CMT1F Charcot–Marie–Tooth disease type 1F CMT1X Charcot–Marie–Tooth disease type 1X CMT2 Charcot–Marie–Tooth disease type 2 COFS Cerebro-oculo-facio-skeletal syndrome: COLD Chronic obstructive lung disease: COPD Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease is a respiratory disease that can encompass chronic bronchitis and/or emphysema. 15% of the cases of COPD in the United States can be attributed to occupational exposure, including exposure to silica and coal dust. People who work in mining, construction, manufacturing (specifically textiles, rubber ...
Diagnosis of obstructive disease requires several factors depending on the exact disease being diagnosed. However one commonality between them is an FEV1/FVC ratio less than 0.7, i.e. the inability to exhale 70% of their breath within one second. [11] Following is an overview of the main obstructive lung diseases.
Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production and/or exacerbations) due to abnormalities of the airways (bronchitis ...
An acute exacerbation of chronic obstructive pulmonary disease, or acute exacerbations of chronic bronchitis (AECB), is a sudden worsening of chronic obstructive pulmonary disease (COPD) symptoms including shortness of breath, quantity and color of phlegm that typically lasts for several days.
In obstructive lung disease, the FEV1 is reduced due to an obstruction of air escaping from the lungs. Thus, the FEV1/FVC ratio will be reduced. [4] More specifically, according to the National Institute for Clinical Excellence, the diagnosis of COPD is made when the FEV 1 /FVC ratio is less than 0.7 or [8] the FEV 1 is less than 75% of predicted; [9] however, other authoritative bodies have ...
Pulmonary function testing is a diagnostic and management tool used for a variety of reasons, such as: Diagnose lung disease. Monitor the effect of chronic diseases like asthma, chronic obstructive lung disease, or cystic fibrosis. Detect early changes in lung function. Identify narrowing in the airways. Evaluate airway bronchodilator reactivity.
Decrease of total lung area, e.g. Restrictive lung disease or lung resection (partial or total). Chronic obstructive pulmonary disease (Emphysema) due to decreased surface area in the alveoli, as well as damage to the capillary bed [7] Pulmonary embolism; Cardiac insufficiency [8] Pulmonary hypertension; Bleomycin (upon administration of more ...